Skip to content

The application of Yesucom eye drops in children with orthokeratology lens

The application of Yesucom eye drops in children with orthokeratology lens

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500108773
Enrollment
Unknown
Registered
2025-09-04
Start date
2025-09-05
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopia

Interventions

Experimental group: Yesucom contact lens eye moisturizer:Participants were randomly assigned to use different eye moisturizers in both eyes. Each participant will be assigned a unique participant numb
Control group: 0.1% sodium hyaluronate eye drops:Participants were randomly assigned to use different eye moisturizers in both eyes. Each participant will be assigned a unique participant number throu

Sponsors

Eye & ENT Hospital of Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
8 Years to 18 Years

Inclusion criteria

Inclusion criteria: 1) 8 years old <= age <= 18 years old, regardless of gender; 2) wearing orthokeratology lenses of the same brand and design for both eyes; 3) did not wear any contact lens within one month before enrollment; 4) anisometropia < -2.00D; 5) There were no severe dry eye and other ocular surface diseases that might affect the results before orthokeratology lens wearing; 6) no use of dry eye medication in the 7 days before enrollment; 7) no use of atropine eye drops for 10 days before enrollment 8) no history of corneal refractive surgery in both eyes; 9) The patients could understand the purpose of the trial, voluntarily participate in the trial, sign the informed consent form by the patients or their legal guardians, and complete the follow-up on time;

Exclusion criteria

Exclusion criteria: 1) diagnosed as severe dry eye 2) poor fit of orthokeratology lenses or serious precipitation or scratch of the lenses according to the investigator's judgment, need to replace the lenses or stop wearing them; 3) any infectious or non-infectious eye diseases such as corneal ulcer, conjunctivitis, scleritis, uveitis; 4) any ocular trauma, ocular tumor, glaucoma, cataract, fundus disease and other ocular diseases that need further treatment; 5) accompanied by severe or unstable heart, liver, kidney, lung, endocrine (including thyroid insufficiency), blood, mental and nervous dysfunction and other diseases; 6) patients with diabetes mellitus; 7) current use or planned use during the study of medications that may cause dry eye; 8) other conditions judged by the investigator to be ineligible

Design outcomes

Primary

MeasureTime frame
Tear film quality check;Slit-lamp examination;Corneal fluorescein staining was performed;The anterior segment was photographed after corneal fluorescein staining;Tear river height;Questionnaire survey;

Countries

China

Contacts

Public ContactChen Zhi

Eye & ENT Hospital of Fudan University

peter459@aliyun.com+86 136 0420 2085

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026